Resource Search

Results: 249

The EPP Expert Board members read - and select - for you the ‘must’ read books, articles and whitepapers for pricing practitioners.  
EPP Connect&More is another great source for pricing professionals, managed by a team of industry contributors. 
* Sign-up to receive the free monthly EPP Connect&More : here
* Some content in the EPP Content database is reserved for EPP Members only ;  sign-up : here


EPP Thought Leadership Series 1/2019

Edition 1/2019 : The evolving landscape of Biosimilars and it”s impact on the public procurement and Tendering environment

Highpoint, an IQVIA company, has conducted various analysis to assess the impact of tenders for biosimilars and observed recent market trends as well as manufacturer behaviors to capture the subtle changes. Our findings translate into a comprehensive view on how companies could improve their bidding and tender strategy to succeed in this space. lastly, we provide our outlook on this topic emphasizing the importance for all stakeholders to find the right balance between cost containment for payers and sustainability for manufacturers to ensure that ultimately, patients and physicians will have multiple treatment options available.

The EPP® Thought Leadership Series provide insights from pricing leaders around the globe. When a new insight breaks, these pricing leaders already think of the unanswered questions and the story behind the story.  These people want to inspire you to act - to take the next step in your journey. With these series, we help to take the right actions.

  • Author(s): EPP Thought Leadership Series
  • Uploaded on: 26/07/2019
  • Content Type: Articles

EPP Thought Leadership Series 2/2019

Edition 2/2019: 7 Steps for Success in Tender Management

Change and taking action usually starts with either inspiration or desperation. You could be inspired and intrigued by the opportunities and possibilities that something offers. Or you are desperate and disappointed about the fact that things do not go the way you want them to go and you are almost forced to change something. This also applies to Tendering.

 The EPP® Thought Leadership Series provide insights from pricing leaders around the globe. When a new insight breaks, these pricing leaders already think of the unanswered questions and the story behind the story.  These people want to inspire you to act - to take the next step in your journey. With these series, we help to take the right actions.

 

 

  • Author(s): Lena Chatchatrian
  • Uploaded on: 24/07/2019
  • Content Type: Articles

Tendering and Contracting - Industry Trends

With 25% of the pharmaceutical market worldwide going through some form of T&C, you are far from alone. We expect, in both developed and emerging countries that trend to not only continue, but increase. Consequently, the importance for Life Sciences companies to build a succesful tendering and contracting governance globally increases as well. 

  • Author(s): Lena Chatchatrian
  • Uploaded on: 01/08/2019
  • Content Type: Articles

Samsung : the value of a foldable screen

Samsung finally unveiled a foldable screen, the Infinity Flex display, and showed off a prototype of a mysterious foldable-flexible phone.  The flexible display certainly has added value, but how much ?  Will be interesting to see the price tag..

  • Author(s): Morgan Leecy
  • Uploaded on: 03/02/2019
  • Content Type: Connect & More

Insights into Public Procurement for Life Sciences Companies

 

With public procurement growing across industries, Life Sciences companies are no exception to the rule. Indeed, 25% of the pharmaceutical market is now considered to be traded through some form of tender. Tenders are a specific form of centralized procurement where government or any level of health authorities are enforcing competition for a product.

 

  • Author(s): Lena Chatchatrian
  • Uploaded on: 16/04/2019
  • Content Type: Articles

Novartis : the value pricing challenge

Novartis CEO Vas Narasimhan spoke with J.P. Morgan analyst Richard Vosser and the part on value based pricing in pharma is especially interesting.

  • Author(s): Morgan Leecy
  • Uploaded on: 03/02/2019
  • Content Type: Connect & More

From Contextual Pricing to Multichannel pricing : are retailer ready ?

Contextual pricing is not new of course.  An interesting book was written in 2011 already (Contextual Pricing: The Death of List Price and the New Market Reality) , but mulit-channeled pricing is still in discussion.  Most brand marketeers have invested in ‘Occasion Based Packaging’ with differentiated pricing per channel, but are retailers mastering their own channels in the most effective way when it comes to pricing ?  Just came across an interesting article on SloanReview on the multi-channel pricing challenges.

  • Author(s): Morgan Leecy
  • Uploaded on: 03/02/2019
  • Content Type: Connect & More

Video : The Augmented Pricing Manager

Presentation of Manu Carricano on the 13th EPP Global Pricing Forum.

CLICK AND WATCH THE VIDEO BELOW

  • Author(s): Manu Carricano
  • Uploaded on: 11/10/2018
  • Content Type: Videos

Netflix

Netflix could make a unprecedented pricing move as Bloomberg reports. Netflix is known to at least maintain or raise pricing in the key markets where it operates, but it it is the second time in a month that Netflix has admitted it might be looking at a lower-priced subscription tier in certain markets.

  • Author(s): Morgan Leecy
  • Uploaded on: 03/02/2019
  • Content Type: Connect & More

EPP Thought Leadership Series 4/2018

Edition 4/2018 : GCC-DR Price Harmonization and the Effects of ERP

Through the Gulf Central Committ ee for Drug Registration (GCC-DR), Saudi Arabia, Bahrain, Oman, and other Arabian Peninsula nations have sought to rein in the rising costs of drugs through price harmonization. The inter-peninsular reference pricing effect has incited price cuts for the GCC-DR countries, most noticeably since 2014, when the harmonization effort went into full effect.  While the GCC-DR countries rely on one another and, most often, Saudi Arabia, to attain the best pricing for a drug, these countries simultaneously use external reference pricing (ERP ) to seek the lowest price possible for a medicine. Recently, South Korea has been officially added to Saudi Arabia’s list of published reference countries. The Asian country is known for having low cost drugs; in turn, Saudi’s trans-continental reliance on South Korea – albeit done inconsistently – has helped to lower the cost of expensive pharmaceuticals, particularly
biologics for cancer.

The EPP® Thought Leadership Series provide insights from pricing leaders around the globe. When a new insight breaks, these pricing leaders already think of the unanswered questions and the story behind the story.  These people want to inspire you to act - to take the next step in your journey. With these series, we help to take the right actions.

  • Author(s): EPP Thought Leadership Series
  • Uploaded on: 17/12/2017
  • Content Type: Articles